NS Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Home » News » Company News » Inflammatix raises $102m funding for novel immune response diagnostics portfolio » lab test

Inflammatix raises $102m funding for novel immune response diagnostics portfolio

NS Medical Devices is using cookies

Inflammatix has secured $102m funding for novel immune response diagnostics portfolio. (Credit: Michal Jarmoluk from Pixabay)

Related Article

Biggest players in the global wound care market

RECOMMENDED COMPANIES

MOST READ

GE HealthCare, Elekta expand collaboration to boost radiation therapy

Ambu secures FDA nod for new version of aScope Duodeno 2 solution

MGI Tech to advance genomics technology in Latin America

Concept Medical enrols first patient in MagicTouch system’s IDE study

Immunovia’s next-gen pancreatic cancer test yields positive results in trial

Recommended Whitepaper